Home Search

ctxr - search results

If you're not happy with the results, please do another search
Citius Pharma

Citius Pharma (CTXR) $1.20. Price Target Upped to $4.00 at HC Wainright.

STREET INSIDER H.C. Wainwright analyst Vernon Bernardino raised the price target on Citius Pharmaceuticals...
Citius Pharmaceutical, CTXR, Biotech Stock Review

New Report: Citius Pharma (CTXR) Now Our #1 Ranked Idea for 2020.

Citius Pharmaceuticals (CTXR) is hands down one of the most exciting long-term opportunities we have come across since we first launched the...

Citius Pharma (CTXR) Corporate Presentation (Jan 2020).

In the above graphic, the catheter can get infected by bacteria and most typically see evidence of the infection (see gross graphic...

Citius Pharma (CTXR), Fortress Biotech (FBIO) and True Nature (TNTY) Significantly Higher on News.

Fortress Bio (FBIO, $2.42) Up 43%, Citius Pharma (CTXR, $1.15) Up 109% and True Nature Holdings (TNTY, $0.043) Up 117%, Since Adding...
steven boyd, biotech stock review

Armistice Capital Master Fund Ltd., and Citius Pharma (CTXR).

April 2019 Offering On April 1, 2019, Citius entered into securities purchase agreements with institutional investors and accredited investors...

Adding Citius (CTXR) $0.55 to Watch List.

Best Presentation at Dawson James Conference. We attended the Dawson James Conference on October 29th, which had over 20...
candida auris, citius pharma, biotech stock review

Citius Pharma’s (CTXR) Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris.

CRANFORD, N.J., May 13, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug...

Top Presenters, Dawson James 8th Annual Investor Conference.

..And The Winners Are. The recent Dawson James 8th Annual Investor Conference was the bomb, with over 30 companies...

Dawson James Securities 8th Annual Small Cap Growth Conference.

Presenting Company List JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) — via InvestorWire — Dawson James Securities, Inc. (“Dawson”), a full-service...

Dawson James Securities Small Cap Growth Conference | Jupiter, FL | October 12th

Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference. JUPITER, Fla., Sept. 21, 2023 (GLOBE...

Latest article

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!